LOLDX | SSTLX | LOLDX / SSTLX | |
Total Expense Ratio | 0.32 | 1.03 | 31% |
Annual Report Gross Expense Ratio | 0.32 | 1.03 | 31% |
Fund Existence | 8 years | 23 years | - |
Gain YTD | 3.721 | 3.351 | 111% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 42.7B | 256M | 16,680% |
Annual Yield % from dividends | 5.32 | 3.80 | 140% |
Returns for 1 year | 5.74 | 4.44 | 129% |
Returns for 3 years | 14.90 | 11.48 | 130% |
Returns for 5 years | 14.17 | 6.73 | 211% |
Returns for 10 years | N/A | 18.32 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
VYLD | 26.12 | 0.30 | +1.17% |
Inverse Vix Short-Term Futures Etns Due March 22, 2045 | |||
STEW | 18.09 | 0.09 | +0.50% |
SRH Total Return Fund | |||
KLIP | 32.80 | 0.02 | +0.05% |
KraneShares KWEB Covered Call Strat ETF | |||
VIDI | 31.02 | -0.07 | -0.22% |
Vident International Equity Strategy ETF | |||
HELX | 29.28 | -0.20 | -0.69% |
Franklin Genomic Advancements ETF |